SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-053939
Filing Date
2024-05-07
Accepted
2024-05-07 07:19:17
Documents
78
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q beam-20240331.htm   iXBRL 10-Q 1739239
2 EX-10.1 beam-ex10_1.htm EX-10.1 19045
3 EX-10.2 beam-ex10_2.htm EX-10.2 15396
4 EX-31.1 beam-ex31_1.htm EX-31.1 16481
5 EX-31.2 beam-ex31_2.htm EX-31.2 16438
6 EX-32.1 beam-ex32_1.htm EX-32.1 9312
7 EX-32.2 beam-ex32_2.htm EX-32.2 9343
8 GRAPHIC img138500502_0.jpg GRAPHIC 240279
  Complete submission text file 0000950170-24-053939.txt   8756614

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT beam-20240331.xsd EX-101.SCH 1327250
82 EXTRACTED XBRL INSTANCE DOCUMENT beam-20240331_htm.xml XML 1622296
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39208 | Film No.: 24919601
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)